Skip to main content
Lyrea avatar

Not yet reviewed — this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

Mefloquine

This article is a stubmissing:
Subjective Effects
Pharmacology
Tolerance
History & Culture
Mefloquine molecule structureMefloquine molecule structure
Lariam, Mephaquin, WR-177602, WR142490

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Strong250 mg
Heavy250+ mg

The upper dosage value listed reflects the highest dose reported in available experience accounts rather than a formally established ceiling.

Subjective Effects

Subjective Effects not written up yet

Pharmacology

Pharmacology not written up yet

Interactions

Caution

Use caution

These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.

AbametapirAbemaciclibAbrocitinibAcebutololAcenocoumarol
Powered by TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Toxicity

Hepatic

Mefloquine is metabolized primarily through the liver, and impaired hepatic function may prolong elimination, resulting in higher plasma levels and increased risk of adverse reactions.

Cardiovascular

Mefloquine may cause abnormalities with heart rhythms visible on electrocardiograms, including QTc interval prolongation.

Musculoskeletal

Mefloquine is classified as an agent causing muscle toxicity.

Antibiotic Function
Confirmed

Mefloquine is an antimalarial medication used to prevent malaria and to treat the infection.

Psychosis Risk

Psychiatric effects include nightmares, visual and auditory hallucinations, anxiety, depression, unusual behavior, and suicidal ideations. The FDA added a boxed warning in 2013 regarding neuropsychiatric side effects that may persist for months to years after discontinuation or may be permanent. Central nervous system events requiring hospitalization occur in approximately 1 in 10,000 people taking mefloquine for prophylaxis, while milder events such as vivid dreams and insomnia affect up to 25% of users. Mefloquine is contraindicated in those with a history of psychiatric disorders.

Seizure Risk

Mefloquine reduces seizure threshold and neurological side effects include seizures. The drug is contraindicated in those with a previous history of seizures. Neurologic effects can occur at any time during use and may persist for months to years after discontinuation or become permanent.

History & Culture

History & Culture not written up yet

Legality

By Country

Prescription4
United States flagUnited StatesPrescription only
Canada flagCanadaPrescription only
Singapore flagSingaporePrescription only
United Kingdom flagUnited KingdomPrescription only

References

Source Pages

  1. Drug Users Bible by Dominic Milton Trott
  2. DrugBank
  3. DrugBank: Mefloquine Hydrochloride
  4. DrugBank: Mefloquine side effects
  5. DrugBank: Mefloquine syndrome
  6. Wikipedia

Citations

  1. Prescription Drug List: Human Use. hpr-rps.hres.ca (n.d.). https://hpr-rps.hres.ca/pdl-phu.php1
  2. The Prescription Drug List: Access the list and notices. canada.ca (n.d.). https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/access-list-notices.html1
  3. Food and Drugs Act. laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/acts/f-27/section-29.1.html1
  4. Food and Drug Regulations. laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/regulations/C.R.C.%2C_c._870/section-A.01.010.html1
  5. Food and Drug Regulations. laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/regulations/C.R.C.%2C_c._870/section-C.01.041.html1
  6. Search results summary. health-products.canada.ca (n.d.). https://health-products.canada.ca/dpd-bdpp/search-fast-recherche-rapide?lang=eng&no=01242270011
  7. Product information. health-products.canada.ca (n.d.). https://health-products.canada.ca/dpd-bdpp/info?code=68334&lang=eng1
  8. Health Products (Therapeutic Products) Regulations 2016 — Second Schedule, Part 1. sso.agc.gov.sg (n.d.). https://sso.agc.gov.sg/SL/HPA2007-S329-2016?ProvIds=Sc2-1
  9. Health Products (Therapeutic Products) Regulations 2016 — regulation 11. sso.agc.gov.sg (n.d.). https://sso.agc.gov.sg/SL/HPA2007-S329-2016?ProvIds=pr11-1
  10. Reclassification process | Health Sciences Authority. hsa.gov.sg (n.d.). https://www.hsa.gov.sg/therapeutic-products/registration-of-therapeutic-products/variation-application/reclassification/apply-for-reclassification/1

Further Reading

  1. FDA Mefloquine Label (2008)
  2. Karle et al. 2014: Mefloquine and Psychotomimetics Share Neurotransmitter Receptor Interactions
  3. Mayo Clinic: Mefloquine Dosage
  4. MedlinePlus: Mefloquine Drug Information
  5. NCBI Bookshelf: Assessment of Long-Term Health Effects of Antimalarial Drugs
  6. PubChem: Mefloquine

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed — this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Recent changes7 human edits · latest

Times are UTCNewest first

24 January 2026

  1. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  2. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  3. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  4. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  5. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  6. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  7. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

All changes to this article · Site-wide recent changes

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the Mefloquine article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.